These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 21987061)

  • 41. A focus on antiarrhythmic properties of ranolazine.
    Vizzardi E; D'Aloia A; Quinzani F; Bonadei I; Rovetta R; Bontempi L; Curnis A; Dei Cas L
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):353-6. PubMed ID: 22492919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. hERG1 channel activators: a new anti-arrhythmic principle.
    Grunnet M; Hansen RS; Olesen SP
    Prog Biophys Mol Biol; 2008; 98(2-3):347-62. PubMed ID: 19351523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac electrophysiological effects of nitric oxide.
    Tamargo J; Caballero R; Gómez R; Delpón E
    Cardiovasc Res; 2010 Sep; 87(4):593-600. PubMed ID: 20587506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
    Nattel S
    Cardiovasc Res; 2002 May; 54(2):347-60. PubMed ID: 12062340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias.
    Jackson CM; Blass B; Coburn K; Djandjighian L; Fadayel G; Fluxe AJ; Hodson SJ; Janusz JM; Murawsky M; Ridgeway JM; White RE; Wu S
    Bioorg Med Chem Lett; 2007 Jan; 17(1):282-4. PubMed ID: 17095219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.
    Skibsbye L; Ravens U
    Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias.
    Brendel J; Peukert S
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):273-87. PubMed ID: 15326917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological modulations of cardiac ultra-rapid and slowly activating delayed rectifier currents: potential antiarrhythmic approaches.
    Islam MA
    Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):33-46. PubMed ID: 19929823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of ionic remodeling on cardiac antiarrhythmic drug actions.
    Nattel S
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):809-11. PubMed ID: 11707683
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.
    Schmitt N; Grunnet M; Olesen SP
    Physiol Rev; 2014 Apr; 94(2):609-53. PubMed ID: 24692356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Geraniol blocks calcium and potassium channels in the mammalian myocardium: useful effects to treat arrhythmias.
    de Menezes-Filho JE; Gondim AN; Cruz JS; de Souza AA; Santos JN; Conde-Garcia EA; de Sousa DP; Santos MS; de Oliveira ED; de Vasconcelos CM
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):534-44. PubMed ID: 24862086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blockers of the slowly delayed rectifier potassium IKs channel: potential antiarrhythmic agents.
    Gerlach U
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):243-52. PubMed ID: 15326915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel anti-arrhythmic drugs for atrial fibrillation management.
    Ehrlich JR; Nattel S; Hohnloser SH
    Curr Vasc Pharmacol; 2007 Jul; 5(3):185-95. PubMed ID: 17627562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy.
    Diness JG; Bentzen BH; Sørensen US; Grunnet M
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):441-8. PubMed ID: 25830485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channels.
    Simó-Vicens R; Sauter DRP; Grunnet M; Diness JG; Bentzen BH
    Eur J Pharmacol; 2017 May; 803():118-123. PubMed ID: 28322838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metformin restores electrophysiology of small conductance calcium-activated potassium channels in the atrium of GK diabetic rats.
    Fu X; Pan Y; Cao Q; Li B; Wang S; Du H; Duan N; Li X
    BMC Cardiovasc Disord; 2018 Apr; 18(1):63. PubMed ID: 29636010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atria-selective antiarrhythmic drugs in need of alliance partners.
    Peyronnet R; Ravens U
    Pharmacol Res; 2019 Jul; 145():104262. PubMed ID: 31059791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SK channels and ventricular arrhythmias in heart failure.
    Chang PC; Chen PS
    Trends Cardiovasc Med; 2015 Aug; 25(6):508-14. PubMed ID: 25743622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The research practice of anti-arrhythmic agents targeting on potassium ion channel].
    Yang Q; Wang XJ; Tang YQ; You QD
    Yao Xue Xue Bao; 2011 Jan; 46(1):12-8. PubMed ID: 21465803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation.
    Tamargo J; Caballero R; Gómez R; Delpón E
    Expert Opin Investig Drugs; 2009 Apr; 18(4):399-416. PubMed ID: 19335273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.